版本:
中国

BRIEF-Zafgen initiates multiple ascending dose cohorts in early stage clinical trial of ZGN-1061

Sept 20 Zafgen Inc

* Zafgen initiates multiple ascending dose cohorts in phase 1 clinical trial of ZGN-1061

* Company continues to expect top-line data from clinical trial by end of Q1 of 2017. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐